AbbVie (NYSE: ABBV ) has been raising its dividend annually for more than 50 years and is thus a Dividend King, if we include the years before the split with Abbott Labs ( ABT ). UnusuallyI have been an investor for a number of years mainly focusing on dividend paying companies. I think dividends and, perhaps more importantly, the growth of them, are foundational for high risk-adjusted long term returns. My approach is therefore to focus on stocks that either pay stable and high dividends and/or are increas ...